Show simple item record

dc.rights.licenseRestricted to current Rensselaer faculty, staff and students. Access inquiries may be directed to the Rensselaer Libraries.
dc.contributorDordick, Jonathan S.
dc.contributorLinhardt, Robert J.
dc.contributorTessier, Peter M.
dc.contributorKarande, Pankaj
dc.contributorGilbert, Ryan
dc.contributor.authorSterner, Eric Russell
dc.date.accessioned2021-11-03T08:11:01Z
dc.date.available2021-11-03T08:11:01Z
dc.date.created2014-09-11T11:14:41Z
dc.date.issued2014-05
dc.identifier.urihttps://hdl.handle.net/20.500.13015/1132
dc.descriptionMay 2014
dc.descriptionSchool of Engineering
dc.description.abstractAdditionally, due to the tremendous number of physiological pathways with which heparan sulfates are implicated, a comprehensive study of the critical structure and chemical compositions required for binding and activation remains partially studied. Detailed studies on how GAGs with various structures influence growth factor binding and signal transduction initiation have been extensively studied using a combinatorial approach involving cell-based microarrays.
dc.description.abstractGlycosaminoglycans (GAGs) represent a division of carbohydrate chemistry with research applications in a variety of engineering, analytical, and biological disciplines. Heparan sulfate, and the structurally related GAG heparin, have been identified as the most important GAGs due to their biological and pharmacological potential. The issues associated with heparan sulfate and heparin research and production are important for the generation of industrial, medical, and academic targets.
dc.description.abstractHeparin is a therapeutic that can no longer be reliably produced from an animal source. Fluctuations in available animal resources, variability in manufactured animal products, and gaps in current good manufacturing processes add substantial economic burden to the consumer. The potential of heparin as a bioengineered therapeutic will drive the global supply of the pharmaceutical, ensuring the manufacturing safety and relieving patient costs.
dc.language.isoENG
dc.publisherRensselaer Polytechnic Institute, Troy, NY
dc.relation.ispartofRensselaer Theses and Dissertations Online Collection
dc.subjectChemical and biological engineering
dc.titleBioengineering heparin : advanced enzymatic, analytical, and biological techniques
dc.typeElectronic thesis
dc.typeThesis
dc.digitool.pid172738
dc.digitool.pid172740
dc.digitool.pid172742
dc.rights.holderThis electronic version is a licensed copy owned by Rensselaer Polytechnic Institute, Troy, NY. Copyright of original work retained by author.
dc.description.degreePhD
dc.relation.departmentDept. of Chemical and Biological Engineering


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record